Cellular mechanisms underlying central sensitization in a mouse model of chronic muscle pain

Yu Ling Lin, Zhu Sen Yang, Wai Yi Wong, Shih Che Lin, Shuu Jiun Wang, Shih Pin Chen, Jen Kun Cheng, Hui Lu, Cheng Chang Lien*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


Chronic pain disorders are often associated with negative emotions, including anxiety and depression. The central nucleus of the amygdala (CeA) has emerged as an integrative hub for nociceptive and affective components during central pain development. Prior adverse injuries are precipitating factors thought to transform nociceptors into a primed state for chronic pain. However, the cellular basis underlying the primed state and the subsequent development of chronic pain remains unknown. Here, we investigated the cellular and synaptic alterations of the CeA in a mouse model of chronic muscle pain. In these mice, local infusion of pregabalin, a clinically approved drug for fibromyalgia and other chronic pain disorders, into the CeA or chemogenetic inactivation of the somatostatin-expressing CeA (CeA-SST) neurons during the priming phase prevented the chron-ification of pain. Further, electrophysiological recording revealed that the CeA-SST neurons had increased excitatory synaptic drive and enhanced neuronal excitability in the chronic pain states. Finally, either chemogenetic inactivation of the CeA-SST neurons or pharmacological suppression of the nociceptive afferents from the brainstem to the CeA-SST neurons alleviated chronic pain and anxio-depressive symptoms. These data raise the possibility of targeting treatments to CeA-SST neurons to prevent central pain sensitization.

Original languageEnglish
Article numbere78610
StatePublished - Nov 2022


Dive into the research topics of 'Cellular mechanisms underlying central sensitization in a mouse model of chronic muscle pain'. Together they form a unique fingerprint.

Cite this